BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 553791 O=c1cc(C2CCNCC2)n2nc3ccccc3c2[nH]1 InChI=1S/C15H16N4O/c20-14-9-13(10-5-7-16-8-6-10)19-15(17-14)11-3-1-2-4-12(11)18-19/h1-4,9-10,16H,5-8H2,(H,17,20) HPNRKQHUJWHTEL-UHFFFAOYSA-N 290260 US10098883, Example 1::4-(Piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 1 Plasminogen [101-181] Human 51.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290260&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528546 381610591 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553792 FC(F)(F)c1ccc2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C16H15F3N4O/c17-16(18,19)10-1-2-12-11(7-10)15-21-14(24)8-13(23(15)22-12)9-3-5-20-6-4-9/h1-2,7-9,20H,3-6H2,(H,21,24) GFNFRFNJUILJLD-UHFFFAOYSA-N 290261 US10098883, Example 2::4-(Piperidin-4-yl)-9-(trifluoromethyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 2 Plasminogen [101-181] Human 30.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290261&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528547 381610592 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553793 Clc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H15ClN4O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) JCSOBBNZRLXNCX-UHFFFAOYSA-N 290262 10-Chloro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 66::US10098883, Example 3::US10668071, Example 66 Plasminogen [101-181] Human 28.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290262&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528548 381610593 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553794 Fc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H15FN4O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) RHUQDSVUQAZXCT-UHFFFAOYSA-N 290263 US10098883, Example 4::10-Fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 4 Plasminogen [101-181] Human 28.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290263 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290263&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528549 381610594 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553795 Clc1ccc2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C15H15ClN4O/c16-10-1-2-12-11(7-10)15-18-14(21)8-13(20(15)19-12)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6H2,(H,18,21) PRICXLGTYNSXDL-UHFFFAOYSA-N 290264 US10098883, Example 5::9-Chloro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 5 Plasminogen [101-181] Human 37.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290264&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528550 381610595 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553796 Clc1cc(Cl)c2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C15H14Cl2N4O/c16-9-5-10-14(11(17)6-9)20-21-12(7-13(22)19-15(10)21)8-1-3-18-4-2-8/h5-8,18H,1-4H2,(H,19,22) SSHONGPABJSMOF-UHFFFAOYSA-N 290265 US10098883, Example 6::7,9-Dichloro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 6 Plasminogen [101-181] Human 94.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290265 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290265&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528551 381610596 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553797 Fc1ccc2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C15H15FN4O/c16-10-1-2-12-11(7-10)15-18-14(21)8-13(20(15)19-12)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6H2,(H,18,21) JXXOFJAXELERBQ-UHFFFAOYSA-N 290266 US10098883, Example 7::9-Fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 7 Plasminogen [101-181] Human 95.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290266&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528552 381610597 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553798 COc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C16H18N4O2/c1-22-13-4-2-3-11-15(13)16-18-14(21)9-12(20(16)19-11)10-5-7-17-8-6-10/h2-4,9-10,17H,5-8H2,1H3,(H,18,21) WQLRCDTYQYYYQO-UHFFFAOYSA-N 290267 US10098883, Example 8::10-Methoxy-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 8 Plasminogen [101-181] Human 46.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290267 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290267&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528553 381610598 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553799 O=c1cc(C2CCNCC2)n2nc3cccnc3c2[nH]1 InChI=1S/C14H15N5O/c20-12-8-11(9-3-6-15-7-4-9)19-14(17-12)13-10(18-19)2-1-5-16-13/h1-2,5,8-9,15H,3-4,6-7H2,(H,17,20) HGLONKBLUQHOKG-UHFFFAOYSA-N 290268 US10098883, Example 9::7-(Piperidin-4-yl)pyrido[3′,2′:3,4]pyrazolo[1,5-a]pyrimidin-9(10H)-one hydrochloride::US10668071, Example 9 Plasminogen [101-181] Human 36.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290268 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290268&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528554 381610599 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553800 Brc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H15BrN4O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) BKPYMMXDHTZIRB-UHFFFAOYSA-N 290269 US10098883, Example 60::10-Bromo-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 10::US10668071, Example 60 Plasminogen [101-181] Human 34.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290269&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528555 381610600 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553801 FC(F)(F)c1ccc2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H15F3N4O/c17-16(18,19)10-1-2-11-12(7-10)22-23-13(8-14(24)21-15(11)23)9-3-5-20-6-4-9/h1-2,7-9,20H,3-6H2,(H,21,24) FSHIRUYVKZDVTM-UHFFFAOYSA-N 290270 US10098883, Example 11::4-(Piperidin-4-yl)-8-(trifluoromethyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 11 Plasminogen [101-181] Human 26.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290270 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290270&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528556 381610601 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553802 FC(F)(F)c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C16H15F3N4O/c17-16(18,19)10-2-1-3-11-14(10)15-21-13(24)8-12(23(15)22-11)9-4-6-20-7-5-9/h1-3,8-9,20H,4-7H2,(H,21,24) MWWYRQSZLGEKSJ-UHFFFAOYSA-N 290271 US10098883, Example 12::4-(Piperidin-4-yl)-10-(trifluoromethyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 12 Plasminogen [101-181] Human 32.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290271 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290271&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528557 381610602 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553803 CC(C)(C)c1ccc2c(nn3c(cc(=O)[nH]c23)C2CCNCC2)n1 InChI=1S/C18H23N5O/c1-18(2,3)14-5-4-12-16(20-14)22-23-13(10-15(24)21-17(12)23)11-6-8-19-9-7-11/h4-5,10-11,19H,6-9H2,1-3H3,(H,21,24) ZLFKSRIVXCBDMD-UHFFFAOYSA-N 290272 US10098883, Example 13::8-tert-Butyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10668071, Example 13 Plasminogen [101-181] Human 31.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290272 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290272&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528558 381610603 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553804 Cc1cc(cc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1)C(F)(F)F InChI=1S/C17H17F3N4O/c1-9-6-11(17(18,19)20)7-12-15(9)16-22-14(25)8-13(24(16)23-12)10-2-4-21-5-3-10/h6-8,10,21H,2-5H2,1H3,(H,22,25) VBHILVRYRGNAOU-UHFFFAOYSA-N 290273 US10098883, Example 14::10-Methyl-4-(piperidin-4-yl)-8-(trifluoromethyl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride Plasminogen [101-181] Human 50.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290273 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290273&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528559 381610604 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553805 Cc1ccc2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C16H18N4O/c1-10-2-3-13-12(8-10)16-18-15(21)9-14(20(16)19-13)11-4-6-17-7-5-11/h2-3,8-9,11,17H,4-7H2,1H3,(H,18,21) VPDJLDIIMHAMJP-UHFFFAOYSA-N 290274 US10098883, Example 15::9-Methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 15 Plasminogen [101-181] Human 48.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290274 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290274&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528560 381610605 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553806 Nc1ccc2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H17N5O/c16-10-1-2-11-12(7-10)19-20-13(8-14(21)18-15(11)20)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6,16H2,(H,18,21) SLCFKUHMCXQXHP-UHFFFAOYSA-N 290275 US10098883, Example 16::8-Amino-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 16 Plasminogen [101-181] Human 34.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290275&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528561 381610606 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553807 Cc1nnc2nn3c(cc(=O)[nH]c3c2c1C)C1CCNCC1 InChI=1S/C15H18N6O/c1-8-9(2)18-19-14-13(8)15-17-12(22)7-11(21(15)20-14)10-3-5-16-6-4-10/h7,10,16H,3-6H2,1-2H3,(H,17,22) YYFWEPCJQMLKDX-UHFFFAOYSA-N 290276 US10098883, Example 17::3,4-Dimethyl-8-(piperidin-4-yl)pyrimido[1′,2′:1,5]pyrazolo[3,4-c]pyridazin-6(5H)-one hydrochloride::US10668071, Example 17 Plasminogen [101-181] Human 22.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290276 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290276&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528562 381610607 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553808 Fc1ccc2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H15FN4O/c16-10-1-2-11-12(7-10)19-20-13(8-14(21)18-15(11)20)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6H2,(H,18,21) DZMASZZVHCWZFC-UHFFFAOYSA-N 290277 US10098883, Example 18::8-Fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 18 Plasminogen [101-181] Human 38.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290277 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290277&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528563 381610608 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553809 Brc1ccc2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C15H15BrN4O/c16-10-1-2-12-11(7-10)15-18-14(21)8-13(20(15)19-12)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6H2,(H,18,21) GWVROZAXAXKXKI-UHFFFAOYSA-N 290278 US10098883, Example 19::9-Bromo-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 19 Plasminogen [101-181] Human 26.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290278 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290278&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528564 381610609 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553810 Ic1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H15IN4O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) RPORPQKHOHAYAZ-UHFFFAOYSA-N 290279 US10098883, Example 20::10-Iodo-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 20 Plasminogen [101-181] Human 22.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290279 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290279&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528565 381610610 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553811 Brc1ccc2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H15BrN4O/c16-10-1-2-11-12(7-10)19-20-13(8-14(21)18-15(11)20)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6H2,(H,18,21) RJMLIAUBTZAZAW-UHFFFAOYSA-N 290280 US10098883, Example 21::8-Bromo-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 21 Plasminogen [101-181] Human 30.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290280 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290280&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528566 381610611 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553812 Clc1cccc2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H15ClN4O/c16-11-3-1-2-10-14(11)19-20-12(8-13(21)18-15(10)20)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) OGFDFQQGEVNHMI-UHFFFAOYSA-N 290281 US10098883, Example 22::7-Chloro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 22 Plasminogen [101-181] Human 26.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290281 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290281&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528567 381610612 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553813 Fc1cc(F)c2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H14F2N4O/c16-9-5-10(17)14-11(6-9)20-21-12(7-13(22)19-15(14)21)8-1-3-18-4-2-8/h5-8,18H,1-4H2,(H,19,22) HMVPUPFKGUWTAG-UHFFFAOYSA-N 290282 US10098883, Example 23::8,10-Difluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 23 Plasminogen [101-181] Human 28.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290282 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290282&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528568 381610613 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553814 Cc1ccc2c(nn3c(cc(=O)[nH]c23)C2CCNCC2)n1 InChI=1S/C15H17N5O/c1-9-2-3-11-14(17-9)19-20-12(8-13(21)18-15(11)20)10-4-6-16-7-5-10/h2-3,8,10,16H,4-7H2,1H3,(H,18,21) SNMCZBPEZREHJL-UHFFFAOYSA-N 290283 US10098883, Example 24::8-Methyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10668071, Example 24 Plasminogen [101-181] Human 34.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290283 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290283&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528569 381610614 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553815 Fc1cnc2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C14H14FN5O/c15-9-5-10-13(17-7-9)14-18-12(21)6-11(20(14)19-10)8-1-3-16-4-2-8/h5-8,16H,1-4H2,(H,18,21) ABUQBVRNGFQAQF-UHFFFAOYSA-N 290284 US10098883, Example 25::3-Fluoro-7-(piperidin-4-yl)pyrido[3′,2′:3,4]pyrazolo[1,5-a]pyrimidin-9(10H)-one hydrochloride::US10668071, Example 25 Plasminogen [101-181] Human 21.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290284 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290284&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528570 381610615 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553816 CCOc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C17H20N4O2/c1-2-23-14-5-3-4-12-16(14)17-19-15(22)10-13(21(17)20-12)11-6-8-18-9-7-11/h3-5,10-11,18H,2,6-9H2,1H3,(H,19,22) IYXBEHMDMMXMTH-UHFFFAOYSA-N 290285 US10098883, Example 26::10-Ethoxy-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 26 Plasminogen [101-181] Human 29.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290285 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290285&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528571 381610616 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553817 Brc1cncc2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C14H14BrN5O/c15-10-7-17-6-9-13(10)19-20-11(5-12(21)18-14(9)20)8-1-3-16-4-2-8/h5-8,16H,1-4H2,(H,18,21) DMNCQTDNJQKQQV-UHFFFAOYSA-N 290286 US10098883, Example 27::7-Bromo-4-(piperidin-4-yl)pyrido[4′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10668071, Example 27 Plasminogen [101-181] Human 13.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290286 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290286&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528572 381610617 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553818 Fc1cccc2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H15FN4O/c16-11-3-1-2-10-14(11)19-20-12(8-13(21)18-15(10)20)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) WIABCIDGQJRJRH-UHFFFAOYSA-N 290287 US10098883, Example 28::7-Fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 28 Plasminogen [101-181] Human 33.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290287 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290287&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528573 381610618 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553819 O=c1cc(C2CCNCC2)n2nc3cnccc3c2[nH]1 InChI=1S/C14H15N5O/c20-13-7-12(9-1-4-15-5-2-9)19-14(17-13)10-3-6-16-8-11(10)18-19/h3,6-9,15H,1-2,4-5H2,(H,17,20) KMMAWAMCHYHUQX-UHFFFAOYSA-N 290288 US10098883, Example 29::4-(Piperidin-4-yl)pyrido[3′,4′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10668071, Example 29 Plasminogen [101-181] Human 28.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290288 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290288&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528574 381610619 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553820 FC(F)(F)c1cccc2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H15F3N4O/c17-16(18,19)11-3-1-2-10-14(11)22-23-12(8-13(24)21-15(10)23)9-4-6-20-7-5-9/h1-3,8-9,20H,4-7H2,(H,21,24) ZTPKBFCZDGGBAL-UHFFFAOYSA-N 290289 US10098883, Example 30::4-(Piperidin-4-yl)-7-(trifluoromethyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 30 Plasminogen [101-181] Human 46.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290289 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290289&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528575 381610620 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553821 [O-][N+](=O)c1cc(cc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1)C(F)(F)F InChI=1S/C16H14F3N5O3/c17-16(18,19)9-5-10-14(12(6-9)24(26)27)15-21-13(25)7-11(23(15)22-10)8-1-3-20-4-2-8/h5-8,20H,1-4H2,(H,21,25) CHDYOAPLSOGCCS-UHFFFAOYSA-N 290290 US10098883, Example 31::10-Nitro-4-(piperidin-4-yl)-8-(trifluoromethyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 31 Plasminogen [101-181] Human 97.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290290 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290290&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528576 381610621 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553822 Cc1cc(C)c2c(nn3c(cc(=O)[nH]c23)C2CCNCC2)n1 InChI=1S/C16H19N5O/c1-9-7-10(2)18-15-14(9)16-19-13(22)8-12(21(16)20-15)11-3-5-17-6-4-11/h7-8,11,17H,3-6H2,1-2H3,(H,19,22) RHESWYNPQQFDFT-UHFFFAOYSA-N 290291 US10098883, Example 32::8,10-Dimethyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10668071, Example 32 Plasminogen [101-181] Human 210 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290291 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290291&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528577 381610622 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553823 O=c1cc(C2CCNCC2)n2nc3cccc(C#N)c3c2[nH]1 InChI=1S/C16H15N5O/c17-9-11-2-1-3-12-15(11)16-19-14(22)8-13(21(16)20-12)10-4-6-18-7-5-10/h1-3,8,10,18H,4-7H2,(H,19,22) VARWJCCPAVWDOP-UHFFFAOYSA-N 290292 US10098883, Example 53::2-Oxo-4-(piperidin-4-yl)-1,2-dihydropyrimido[1,2-b]indazole-10-carbonitrile trifluoroacetate::US10098883, Example 33::US10668071, Example 53 Plasminogen [101-181] Human 21.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290292 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290292&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528578 381610623 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553824 Cc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C16H18N4O/c1-10-3-2-4-12-15(10)16-18-14(21)9-13(20(16)19-12)11-5-7-17-8-6-11/h2-4,9,11,17H,5-8H2,1H3,(H,18,21) AUYZSLJCFGTZMG-UHFFFAOYSA-N 290293 US10098883, Example 36::10-Methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 36 Plasminogen [101-181] Human 18.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290293 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290293&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528579 381610624 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553825 FC(F)(F)Oc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C16H15F3N4O2/c17-16(18,19)25-12-3-1-2-10-14(12)15-21-13(24)8-11(23(15)22-10)9-4-6-20-7-5-9/h1-3,8-9,20H,4-7H2,(H,21,24) IWPOEKPSVCPFMS-UHFFFAOYSA-N 290294 US10098883, Example 37::4-(Piperidin-4-yl)-10-(trifluoromethoxy)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 37 Plasminogen [101-181] Human 44.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290294 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290294&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528580 381610625 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553826 O=c1cc(C2CCNCC2)n2nc3nccnc3c2[nH]1 InChI=1S/C13H14N6O/c20-10-7-9(8-1-3-14-4-2-8)19-13(17-10)11-12(18-19)16-6-5-15-11/h5-8,14H,1-4H2,(H,17,20) HJPUROSFQNIPTE-UHFFFAOYSA-N 290295 US10098883, Example 38::7-(Piperidin-4-yl)pyrazino[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-9(10H)-one hydrochloride::US10668071, Example 38 Plasminogen [101-181] Human 60.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290295 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290295&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528581 381610626 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553827 Clc1ccc2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H15ClN4O/c16-10-1-2-11-12(7-10)19-20-13(8-14(21)18-15(11)20)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6H2,(H,18,21) IYEYYIYNTPIERT-UHFFFAOYSA-N 290296 US10098883, Example 39::8-Chloro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 39 Plasminogen [101-181] Human 24.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290296 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290296&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528582 381610627 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553828 CN(C)c1ccnc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C16H20N6O/c1-21(2)11-5-8-18-15-14(11)16-19-13(23)9-12(22(16)20-15)10-3-6-17-7-4-10/h5,8-10,17H,3-4,6-7H2,1-2H3,(H,19,23) ZDWJNBGZTOXAJW-UHFFFAOYSA-N 290297 US10098883, Example 40::10-(Dimethylamino)-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10668071, Example 40 Plasminogen [101-181] Human 38.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290297 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290297&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528583 381610628 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553829 FC(F)(F)c1cc(Cl)c2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H14ClF3N4O/c17-10-5-9(16(18,19)20)6-11-14(10)15-22-13(25)7-12(24(15)23-11)8-1-3-21-4-2-8/h5-8,21H,1-4H2,(H,22,25) UZEYIKKYKOKFPO-UHFFFAOYSA-N 290298 US10098883, Example 41::10-Chloro-4-(piperidin-4-yl)-8-(trifluoromethyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 41 Plasminogen [101-181] Human 23.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290298 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290298&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528584 381610629 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553830 Fc1ccc(cc1)-c1cc(c2c(nn3c(cc(=O)[nH]c23)C2CCNCC2)n1)C(F)(F)F InChI=1S/C21H17F4N5O/c22-13-3-1-11(2-4-13)15-9-14(21(23,24)25)18-19(27-15)29-30-16(10-17(31)28-20(18)30)12-5-7-26-8-6-12/h1-4,9-10,12,26H,5-8H2,(H,28,31) BQGXJQOCDDVKKK-UHFFFAOYSA-N 290299 US10098883, Example 42::8-(4-Fluorophenyl)-4-(piperidin-4-yl)-10-(trifluoromethyl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10668071, Example 42 Plasminogen [101-181] Human 110 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290299 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290299&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528585 381610630 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553831 Brc1cncc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C14H14BrN5O/c15-9-6-17-7-10-13(9)14-18-12(21)5-11(20(14)19-10)8-1-3-16-4-2-8/h5-8,16H,1-4H2,(H,18,21) ZHKBNDBMMKLYTQ-UHFFFAOYSA-N 290300 US10098883, Example 43::10-Bromo-4-(piperidin-4-yl)pyrido[3′,4′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10668071, Example 43 Plasminogen [101-181] Human 100.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290300 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290300&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528586 381610631 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553832 O=c1cc(C2CCNCC2)n2nc3nc(ccc3c2[nH]1)-c1ccccc1 InChI=1S/C20H19N5O/c26-18-12-17(14-8-10-21-11-9-14)25-20(23-18)15-6-7-16(22-19(15)24-25)13-4-2-1-3-5-13/h1-7,12,14,21H,8-11H2,(H,23,26) ZLQHQTMJADACHZ-UHFFFAOYSA-N 290301 US10098883, Example 44::8-Phenyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10668071, Example 44 Plasminogen [101-181] Human 48.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290301 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290301&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528587 381610632 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553833 O=c1cc(C2CCNCC2)n2nc3ncc(cc3c2[nH]1)-c1ccccc1 InChI=1S/C20H19N5O/c26-18-11-17(14-6-8-21-9-7-14)25-20(23-18)16-10-15(12-22-19(16)24-25)13-4-2-1-3-5-13/h1-5,10-12,14,21H,6-9H2,(H,23,26) ZPVLVOJNQVFMTP-UHFFFAOYSA-N 290302 US10098883, Example 45::9-Phenyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10668071, Example 45 Plasminogen [101-181] Human 37.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290302 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290302&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528588 381610633 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553834 O=c1cc(C2CCNCC2)n2nc3nccc(-c4ccccc4)c3c2[nH]1 InChI=1S/C20H19N5O/c26-17-12-16(14-6-9-21-10-7-14)25-20(23-17)18-15(8-11-22-19(18)24-25)13-4-2-1-3-5-13/h1-5,8,11-12,14,21H,6-7,9-10H2,(H,23,26) OJHXCSOJNDGQLJ-UHFFFAOYSA-N 290303 US10098883, Example 46::10-Phenyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10668071, Example 46 Plasminogen [101-181] Human 17.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290303 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290303&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528589 381610634 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553835 Cc1ccnc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H17N5O/c1-9-2-7-17-14-13(9)15-18-12(21)8-11(20(15)19-14)10-3-5-16-6-4-10/h2,7-8,10,16H,3-6H2,1H3,(H,18,21) DZMUXQUVMLDOSJ-UHFFFAOYSA-N 290304 US10098883, Example 47::10-methyl-4-(piperidin-4-yl)pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10668071, Example 47 Plasminogen [101-181] Human 24.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290304 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290304&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528590 381610635 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553836 Ic1ccc2nn3c(cc(=O)[nH]c3c2c1)C1CCNCC1 InChI=1S/C15H15IN4O/c16-10-1-2-12-11(7-10)15-18-14(21)8-13(20(15)19-12)9-3-5-17-6-4-9/h1-2,7-9,17H,3-6H2,(H,18,21) JCPLQHMNSNCYMO-UHFFFAOYSA-N 290305 US10098883, Example 48::9-Iodo-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride Plasminogen [101-181] Human 36.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290305 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290305&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528591 381610636 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553837 O=c1cc(C2CCNCC2)n2nc3ccncc3c2[nH]1 InChI=1S/C14H15N5O/c20-13-7-12(9-1-4-15-5-2-9)19-14(17-13)10-8-16-6-3-11(10)18-19/h3,6-9,15H,1-2,4-5H2,(H,17,20) DPXLRNOLDIASIW-UHFFFAOYSA-N 290306 US10098883, Example 49::4-(Piperidin-4-yl)pyrido[4′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one::US10668071, Example 49 Plasminogen [101-181] Human 36.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290306 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290306&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 136962641 381610637 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553838 CC1CC(CCN1)c1cc(=O)[nH]c2c3c(Br)cccc3nn12 InChI=1S/C16H17BrN4O/c1-9-7-10(5-6-18-9)13-8-14(22)19-16-15-11(17)3-2-4-12(15)20-21(13)16/h2-4,8-10,18H,5-7H2,1H3,(H,19,22) ZILDRMBFDBYSAY-UHFFFAOYSA-N 290307 US10098883, Example 50::(−)-trans-10-Bromo-4-(2-methylpiperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 50 Plasminogen [101-181] Human 14.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290307 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290307&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528592 381610638 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553839 CC1CC(CCN1)c1cc(=O)[nH]c2c3c(ccnc3nn12)-c1ccccc1 InChI=1S/C21H21N5O/c1-13-11-15(7-9-22-13)17-12-18(27)24-21-19-16(14-5-3-2-4-6-14)8-10-23-20(19)25-26(17)21/h2-6,8,10,12-13,15,22H,7,9,11H2,1H3,(H,24,27) QUPXOQCUSLWZBH-UHFFFAOYSA-N 290308 US10098883, Example 51::(−)-trans-4-(2-Methylpiperidin-4-yl)-10-phenylpyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidin-2(1H)-one hydrochloride::US10668071, Example 51 Plasminogen [101-181] Human 15.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290308 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290308&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528593 381610639 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553840 CCOc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNC(C)C1 InChI=1S/C18H22N4O2/c1-3-24-15-6-4-5-13-17(15)18-20-16(23)10-14(22(18)21-13)12-7-8-19-11(2)9-12/h4-6,10-12,19H,3,7-9H2,1-2H3,(H,20,23) SCLACQJRWXKYLZ-UHFFFAOYSA-N 290309 US10098883, Example 52::(−)-trans-10-Ethoxy-4-(2-methylpiperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 52 Plasminogen [101-181] Human 13.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290309 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290309&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528594 381610640 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553841 O=c1cc(C2CCNCC2)n2nc3cccc(C#N)c3c2[nH]1 InChI=1S/C16H15N5O/c17-9-11-2-1-3-12-15(11)16-19-14(22)8-13(21(16)20-12)10-4-6-18-7-5-10/h1-3,8,10,18H,4-7H2,(H,19,22) VARWJCCPAVWDOP-UHFFFAOYSA-N 290292 US10098883, Example 53::2-Oxo-4-(piperidin-4-yl)-1,2-dihydropyrimido[1,2-b]indazole-10-carbonitrile trifluoroacetate::US10098883, Example 33::US10668071, Example 53 Plasminogen [101-181] Human 10.00 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290292 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290292&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528578 381610623 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553842 COc1ccc(cc1)-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C22H22N4O2/c1-28-16-7-5-14(6-8-16)17-3-2-4-18-21(17)22-24-20(27)13-19(26(22)25-18)15-9-11-23-12-10-15/h2-8,13,15,23H,9-12H2,1H3,(H,24,27) VDHQRCWDKVFJBT-UHFFFAOYSA-N 290311 US10098883, Example 54::10-(4-Methoxyphenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 54 Plasminogen [101-181] Human 15.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290311 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290311&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528595 381610641 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553843 FC(F)(F)c1ccc(cc1)-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C22H19F3N4O/c23-22(24,25)15-6-4-13(5-7-15)16-2-1-3-17-20(16)21-27-19(30)12-18(29(21)28-17)14-8-10-26-11-9-14/h1-7,12,14,26H,8-11H2,(H,27,30) NZFZUOWLGZSFLE-UHFFFAOYSA-N 290312 US10098883, Example 55::4-(Piperidin-4-yl)-10-[4-(trifluoromethyl)phenyl]pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 55 Plasminogen [101-181] Human 14.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290312 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290312&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528596 381610642 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553844 O=c1cc(C2CCNCC2)n2nc3cccc(-c4ccccc4)c3c2[nH]1 InChI=1S/C21H20N4O/c26-19-13-18(15-9-11-22-12-10-15)25-21(23-19)20-16(7-4-8-17(20)24-25)14-5-2-1-3-6-14/h1-8,13,15,22H,9-12H2,(H,23,26) QUGXDBXLYYVTOS-UHFFFAOYSA-N 290313 US10098883, Example 56::10-Phenyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 56 Plasminogen [101-181] Human 14.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290313 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290313&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528597 381610643 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553845 Fc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C21H19FN4O/c22-16-6-2-1-4-14(16)15-5-3-7-17-20(15)21-24-19(27)12-18(26(21)25-17)13-8-10-23-11-9-13/h1-7,12-13,23H,8-11H2,(H,24,27) VPTAHBAWJZYJEI-UHFFFAOYSA-N 290314 US10098883, Example 95::10-(2-Fluorophenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 57::US10668071, Example 95 Plasminogen [101-181] Human 13.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290314 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290314&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528598 381610644 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553846 O=c1cc(C2CCNCC2)n2nc3cccc(-c4cccnc4)c3c2[nH]1 InChI=1S/C20H19N5O/c26-18-11-17(13-6-9-21-10-7-13)25-20(23-18)19-15(4-1-5-16(19)24-25)14-3-2-8-22-12-14/h1-5,8,11-13,21H,6-7,9-10H2,(H,23,26) FRVSRKWGOJYWGY-UHFFFAOYSA-N 290315 US10098883, Example 58::4-(Piperidin-4-yl)-10-(pyridin-3-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 58 Plasminogen [101-181] Human 15.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290315 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290315&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528599 381610645 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553847 O=c1cc(C2CCNCC2)n2nc3cccc(-c4ccncc4)c3c2[nH]1 InChI=1S/C20H19N5O/c26-18-12-17(14-6-10-22-11-7-14)25-20(23-18)19-15(2-1-3-16(19)24-25)13-4-8-21-9-5-13/h1-5,8-9,12,14,22H,6-7,10-11H2,(H,23,26) RUSMVUILCGMPLP-UHFFFAOYSA-N 290316 US10098883, Example 59::4-(Piperidin-4-yl)-10-(pyridin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 59 Plasminogen [101-181] Human 16.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290316 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290316&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528600 381610646 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553848 Brc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H15BrN4O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) BKPYMMXDHTZIRB-UHFFFAOYSA-N 290269 US10098883, Example 60::10-Bromo-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 10::US10668071, Example 60 Plasminogen [101-181] Human 14.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290269&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528555 381610600 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553849 O=c1cc(C2CCNCC2)n2nc3cccc(C4CC4)c3c2[nH]1 InChI=1S/C18H20N4O/c23-16-10-15(12-6-8-19-9-7-12)22-18(20-16)17-13(11-4-5-11)2-1-3-14(17)21-22/h1-3,10-12,19H,4-9H2,(H,20,23) YIMXTWHVFLKBCH-UHFFFAOYSA-N 290318 US10098883, Example 61::10-Cyclopropyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 61 Plasminogen [101-181] Human 24.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290318 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290318&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528601 381610647 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553850 CC(C)c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C18H22N4O/c1-11(2)13-4-3-5-14-17(13)18-20-16(23)10-15(22(18)21-14)12-6-8-19-9-7-12/h3-5,10-12,19H,6-9H2,1-2H3,(H,20,23) OWUPQPJVQYHCSV-UHFFFAOYSA-N 290319 US10098883, Example 62::10-Isopropyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 62 Plasminogen [101-181] Human 18.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290319 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290319&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528602 381610648 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553851 O=c1cc(C2CCNCC2)n2nc3cccc(C4CCCC4)c3c2[nH]1 InChI=1S/C20H24N4O/c25-18-12-17(14-8-10-21-11-9-14)24-20(22-18)19-15(13-4-1-2-5-13)6-3-7-16(19)23-24/h3,6-7,12-14,21H,1-2,4-5,8-11H2,(H,22,25) YWHIHFGWPXDHQL-UHFFFAOYSA-N 290320 US10098883, Example 63::10-Cyclopentyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 63 Plasminogen [101-181] Human 13.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290320 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290320&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528603 381610649 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553852 Clc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C21H19ClN4O/c22-16-6-2-1-4-14(16)15-5-3-7-17-20(15)21-24-19(27)12-18(26(21)25-17)13-8-10-23-11-9-13/h1-7,12-13,23H,8-11H2,(H,24,27) GEFBYTYDFYHTGN-UHFFFAOYSA-N 290321 US10098883, Example 64::10-(2-Chlorophenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 64 Plasminogen [101-181] Human 19.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290321 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290321&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528604 381610650 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553853 COc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C22H22N4O2/c1-28-19-8-3-2-5-15(19)16-6-4-7-17-21(16)22-24-20(27)13-18(26(22)25-17)14-9-11-23-12-10-14/h2-8,13-14,23H,9-12H2,1H3,(H,24,27) HAXFUUKOQPVIRI-UHFFFAOYSA-N 290322 US10098883, Example 65::10-(2-Methoxyphenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 65 Plasminogen [101-181] Human 25.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290322 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290322&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528605 381610651 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553854 Clc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H15ClN4O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7H2,(H,18,21) JCSOBBNZRLXNCX-UHFFFAOYSA-N 290262 10-Chloro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 66::US10098883, Example 3::US10668071, Example 66 Plasminogen [101-181] Human 15.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290262&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528548 381610593 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553855 FC(F)(F)c1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C22H19F3N4O/c23-22(24,25)16-6-2-1-4-14(16)15-5-3-7-17-20(15)21-27-19(30)12-18(29(21)28-17)13-8-10-26-11-9-13/h1-7,12-13,26H,8-11H2,(H,27,30) HRTZQFUZXIJCKY-UHFFFAOYSA-N 290324 US10098883, Example 67::4-(Piperidin-4-yl)-10-[2-(trifluoromethyl)phenyl]pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 67 Plasminogen [101-181] Human 13.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290324 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290324&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528606 381610652 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553856 CC1CC(CCN1)c1cc(=O)[nH]c2c3c(Cl)cccc3nn12 InChI=1S/C16H17ClN4O/c1-9-7-10(5-6-18-9)13-8-14(22)19-16-15-11(17)3-2-4-12(15)20-21(13)16/h2-4,8-10,18H,5-7H2,1H3,(H,19,22) GBMDIIOZEVMRKC-UHFFFAOYSA-N 290325 US10098883, Example 68::(−)-trans-10-Chloro-4-(2-methylpiperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 101 Plasminogen [101-181] Human 25.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290325&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528607 381610653 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553857 Cc1ccc2nn3c(cc(=O)[nH]c3c2c1Cl)C1CCNCC1 InChI=1S/C16H17ClN4O/c1-9-2-3-11-14(15(9)17)16-19-13(22)8-12(21(16)20-11)10-4-6-18-7-5-10/h2-3,8,10,18H,4-7H2,1H3,(H,19,22) NIQBDMIDYSLUMX-UHFFFAOYSA-N 290326 US10098883, Example 69::10-Chloro-9-methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 69 Plasminogen [101-181] Human 20.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290326 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290326&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528608 381610654 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553858 Fc1ccc2nn3c(cc(=O)[nH]c3c2c1Br)C1CCNCC1 InChI=1S/C15H14BrFN4O/c16-14-9(17)1-2-10-13(14)15-19-12(22)7-11(21(15)20-10)8-3-5-18-6-4-8/h1-2,7-8,18H,3-6H2,(H,19,22) OCFHKLIUAGLQDX-UHFFFAOYSA-N 290327 US10098883, Example 70::10-Bromo-9-fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 70 Plasminogen [101-181] Human 35.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290327 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290327&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528609 381610655 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553859 Fc1ccc(Br)c2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H14BrFN4O/c16-9-1-2-10(17)14-13(9)15-19-12(22)7-11(21(15)20-14)8-3-5-18-6-4-8/h1-2,7-8,18H,3-6H2,(H,19,22) DFOWSDNPCSTZTD-UHFFFAOYSA-N 290328 US10098883, Example 71::10-Bromo-7-fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 71 Plasminogen [101-181] Human 15.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290328 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290328&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528610 381610656 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553860 CCC(C)c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C19H24N4O/c1-3-12(2)14-5-4-6-15-18(14)19-21-17(24)11-16(23(19)22-15)13-7-9-20-10-8-13/h4-6,11-13,20H,3,7-10H2,1-2H3,(H,21,24) OZONEQYMKZKJLR-UHFFFAOYSA-N 290329 US10098883, Example 72::10-sec-Butyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 72 Plasminogen [101-181] Human 14.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290329 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290329&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528611 381610657 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553861 CC(C)Cc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C19H24N4O/c1-12(2)10-14-4-3-5-15-18(14)19-21-17(24)11-16(23(19)22-15)13-6-8-20-9-7-13/h3-5,11-13,20H,6-10H2,1-2H3,(H,21,24) KFWANCJBWKMZJS-UHFFFAOYSA-N 290330 US10098883, Example 73::10-Isobutyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 73 Plasminogen [101-181] Human 23.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290330 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290330&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528612 381610658 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553862 Cc1ccc2nn3c(cc(=O)[nH]c3c2c1Br)C1CCNCC1 InChI=1S/C16H17BrN4O/c1-9-2-3-11-14(15(9)17)16-19-13(22)8-12(21(16)20-11)10-4-6-18-7-5-10/h2-3,8,10,18H,4-7H2,1H3,(H,19,22) QYSSTLHEYBWPLJ-UHFFFAOYSA-N 290331 US10098883, Example 74::10-Bromo-9-methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 74 Plasminogen [101-181] Human 15.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290331 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290331&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528613 381610659 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553863 Cc1ccc(Br)c2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H17BrN4O/c1-9-2-3-11(17)14-15(9)20-21-12(8-13(22)19-16(14)21)10-4-6-18-7-5-10/h2-3,8,10,18H,4-7H2,1H3,(H,19,22) HNFQVGJYINLRAE-UHFFFAOYSA-N 290332 US10098883, Example 75::10-Bromo-7-methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 75 Plasminogen [101-181] Human 16.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290332 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290332&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528614 381610660 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553864 CC(C)Oc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C18H22N4O2/c1-11(2)24-15-5-3-4-13-17(15)18-20-16(23)10-14(22(18)21-13)12-6-8-19-9-7-12/h3-5,10-12,19H,6-9H2,1-2H3,(H,20,23) JMPSZUYOCQBHEK-UHFFFAOYSA-N 290333 US10098883, Example 76::10-Isopropoxy-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 76 Plasminogen [101-181] Human 15.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290333 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290333&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528615 381610661 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553865 Fc1ccc2nn3c(cc(=O)[nH]c3c2c1-c1ccccc1)C1CCNCC1 InChI=1S/C21H19FN4O/c22-15-6-7-16-20(19(15)14-4-2-1-3-5-14)21-24-18(27)12-17(26(21)25-16)13-8-10-23-11-9-13/h1-7,12-13,23H,8-11H2,(H,24,27) NORWSQPVXYFCFO-UHFFFAOYSA-N 290334 US10098883, Example 77::9-Fluoro-10-phenyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 77 Plasminogen [101-181] Human 11.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290334 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290334&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528616 381610662 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553866 Fc1cccc(F)c1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 |(1.55,5.36,;2.64,4.27,;4.13,4.67,;5.22,3.58,;4.82,2.09,;3.33,1.69,;2.93,.21,;2.24,2.78,;.7,2.78,;.08,4.19,;-1.46,4.35,;-2.36,3.1,;-1.73,1.7,;-2.36,.29,;-1.22,-.74,;-1.22,-2.28,;.12,-3.05,;1.45,-2.28,;2.78,-3.05,;1.45,-.74,;.12,.03,;-.2,1.54,;-2.55,-3.05,;-3.88,-2.28,;-5.22,-3.05,;-5.22,-4.59,;-3.88,-5.36,;-2.55,-4.59,)| InChI=1S/C21H18F2N4O/c22-14-4-2-5-15(23)19(14)13-3-1-6-16-20(13)21-25-18(28)11-17(27(21)26-16)12-7-9-24-10-8-12/h1-6,11-12,24H,7-10H2,(H,25,28) DXKYIFAFNBESMY-UHFFFAOYSA-N 290335 US10098883, Example 78::10-(2,6-Difluorophenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 78 Plasminogen [101-181] Human 15.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290335 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290335&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528617 381610663 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553867 Cc1cc(Cl)c2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H17ClN4O/c1-9-6-11(17)15-12(7-9)20-21-13(8-14(22)19-16(15)21)10-2-4-18-5-3-10/h6-8,10,18H,2-5H2,1H3,(H,19,22) OOCUXPKWDWOLFE-UHFFFAOYSA-N 290336 US10098883, Example 79::10-Chloro-8-methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 79 Plasminogen [101-181] Human 11.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290336 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290336&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528618 381610664 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553868 FC(F)(F)Oc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C22H19F3N4O2/c23-22(24,25)31-18-7-2-1-4-14(18)15-5-3-6-16-20(15)21-27-19(30)12-17(29(21)28-16)13-8-10-26-11-9-13/h1-7,12-13,26H,8-11H2,(H,27,30) AEUWBYNIQAHUAQ-UHFFFAOYSA-N 290337 US10098883, Example 80::4-(Piperidin-4-yl)-10-[2-(trifluoromethoxy)phenyl]pyrimido[1,2-b]indazol-2(1H)-on hydrochloride::US10668071, Example 80 Plasminogen [101-181] Human 18.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290337 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290337&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528619 381610665 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553869 Fc1cc(Br)c2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C15H14BrFN4O/c16-10-5-9(17)6-11-14(10)15-19-13(22)7-12(21(15)20-11)8-1-3-18-4-2-8/h5-8,18H,1-4H2,(H,19,22) ZHLHZRYKLMKZDQ-UHFFFAOYSA-N 290338 US10098883, Example 81::10-Bromo-8-fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 81 Plasminogen [101-181] Human 16.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290338 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290338&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528620 381610666 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553870 O=c1cc(C2CCNCC2)n2nc3cccc(-c4ccccn4)c3c2[nH]1 InChI=1S/C20H19N5O/c26-18-12-17(13-7-10-21-11-8-13)25-20(23-18)19-14(4-3-6-16(19)24-25)15-5-1-2-9-22-15/h1-6,9,12-13,21H,7-8,10-11H2,(H,23,26) HWHUZTMZNGMYEC-UHFFFAOYSA-N 290339 US10098883, Example 82::4-(Piperidin-4-yl)-10-(pyridin-2-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 82 Plasminogen [101-181] Human 20.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290339 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290339&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528621 381610667 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553871 O=c1cc(C2CCNCC2)n2nc3cccc(-c4nccs4)c3c2[nH]1 InChI=1S/C18H17N5OS/c24-15-10-14(11-4-6-19-7-5-11)23-17(21-15)16-12(18-20-8-9-25-18)2-1-3-13(16)22-23/h1-3,8-11,19H,4-7H2,(H,21,24) YRHDRRIEMZBQLD-UHFFFAOYSA-N 290340 US10098883, Example 83::4-(Piperidin-4-yl)-10-(1,3-thiazol-2-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 83 Plasminogen [101-181] Human 41.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290340 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290340&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528622 381610668 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553872 O=c1cc(C2CCNCC2)n2nc3cccc(-c4ccsc4)c3c2[nH]1 InChI=1S/C19H18N4OS/c24-17-10-16(12-4-7-20-8-5-12)23-19(21-17)18-14(13-6-9-25-11-13)2-1-3-15(18)22-23/h1-3,6,9-12,20H,4-5,7-8H2,(H,21,24) RTGPFWOGKHQYMX-UHFFFAOYSA-N 290341 US10098883, Example 84::4-(Piperidin-4-yl)-10-(3-thienyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 84 Plasminogen [101-181] Human 23.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290341 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290341&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528623 381610669 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553873 Cc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C22H22N4O/c1-14-5-2-3-6-16(14)17-7-4-8-18-21(17)22-24-20(27)13-19(26(22)25-18)15-9-11-23-12-10-15/h2-8,13,15,23H,9-12H2,1H3,(H,24,27) MEBQJFIUKMZVGA-UHFFFAOYSA-N 290342 US10098883, Example 85::10-(2-Methylphenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 85 Plasminogen [101-181] Human 18.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290342 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290342&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528624 381610670 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553874 Cn1nccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C19H20N6O/c1-24-15(7-10-21-24)13-3-2-4-14-18(13)19-22-17(26)11-16(25(19)23-14)12-5-8-20-9-6-12/h2-4,7,10-12,20H,5-6,8-9H2,1H3,(H,22,26) PLWXETXSOMLQGU-UHFFFAOYSA-N 290343 US10098883, Example 86::10-(1-Methyl-1H-pyrazol-5-yl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 86 Plasminogen [101-181] Human 15.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290343 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290343&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528625 381610671 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553875 Cn1cc(cn1)-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C19H20N6O/c1-24-11-13(10-21-24)14-3-2-4-15-18(14)19-22-17(26)9-16(25(19)23-15)12-5-7-20-8-6-12/h2-4,9-12,20H,5-8H2,1H3,(H,22,26) UJPCPYLBWIQEJE-UHFFFAOYSA-N 290344 US10098883, Example 87::10-(1-Methyl-1H-pyrazol-4-yl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 87 Plasminogen [101-181] Human 25.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290344 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290344&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528626 381610672 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553876 O=c1cc(C2CCNCC2)n2nc3cccc(-c4cccs4)c3c2[nH]1 InChI=1S/C19H18N4OS/c24-17-11-15(12-6-8-20-9-7-12)23-19(21-17)18-13(16-5-2-10-25-16)3-1-4-14(18)22-23/h1-5,10-12,20H,6-9H2,(H,21,24) UHLPRPUEGYIKTH-UHFFFAOYSA-N 290345 US10098883, Example 88::4-(Piperidin-4-yl)-10-(2-thienyl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 88 Plasminogen [101-181] Human 26.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290345 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290345&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528627 381610673 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553877 Cc1cc(Br)c2c(c1)nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H17BrN4O/c1-9-6-11(17)15-12(7-9)20-21-13(8-14(22)19-16(15)21)10-2-4-18-5-3-10/h6-8,10,18H,2-5H2,1H3,(H,19,22) QBADPMPDDSTWJX-UHFFFAOYSA-N 290346 US10098883, Example 89::10-Bromo-8-methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 89 Plasminogen [101-181] Human 36.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290346 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290346&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528628 381610674 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553878 Fc1ccc2nn3c(cc(=O)[nH]c3c2c1Cl)C1CCNCC1 InChI=1S/C15H14ClFN4O/c16-14-9(17)1-2-10-13(14)15-19-12(22)7-11(21(15)20-10)8-3-5-18-6-4-8/h1-2,7-8,18H,3-6H2,(H,19,22) IDSVUURBHNHJFJ-UHFFFAOYSA-N 290347 US10098883, Example 90::10-Chloro-9-fluoro-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 90 Plasminogen [101-181] Human 24.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290347 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290347&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528629 381610675 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553879 O=c1cc(C2CCNCC2)n2nc3cccc(-n4cncn4)c3c2[nH]1 InChI=1S/C17H17N7O/c25-15-8-14(11-4-6-18-7-5-11)24-17(21-15)16-12(22-24)2-1-3-13(16)23-10-19-9-20-23/h1-3,8-11,18H,4-7H2,(H,21,25) UGSRPIQETZIOTL-UHFFFAOYSA-N 290348 US10098883, Example 91::4-(Piperidin-4-yl)-10-(1H-1,2,4-triazol-1-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 91 Plasminogen [101-181] Human 27.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290348 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290348&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528630 381610676 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553880 Fc1ccccc1-c1c(F)ccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 |(2.19,5.4,;2.96,4.07,;4.5,4.07,;5.27,2.74,;4.5,1.4,;2.96,1.4,;2.19,2.74,;.65,2.74,;.02,4.14,;1.11,5.23,;-1.51,4.31,;-2.41,3.06,;-1.79,1.65,;-2.41,.25,;-1.27,-.78,;-1.27,-2.32,;.06,-3.09,;1.4,-2.32,;2.73,-3.09,;1.4,-.78,;.06,-.01,;-.26,1.49,;-2.6,-3.09,;-3.94,-2.32,;-5.27,-3.09,;-5.27,-4.63,;-3.94,-5.4,;-2.6,-4.63,)| InChI=1S/C21H18F2N4O/c22-14-4-2-1-3-13(14)19-15(23)5-6-16-20(19)21-25-18(28)11-17(27(21)26-16)12-7-9-24-10-8-12/h1-6,11-12,24H,7-10H2,(H,25,28) DCXJGHUGMDPRPO-UHFFFAOYSA-N 290349 US10098883, Example 92::9-Fluoro-10-(2-fluorophenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 92 Plasminogen [101-181] Human 27.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290349 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290349&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528631 381610677 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553881 CCOc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C23H24N4O2/c1-2-29-20-9-4-3-6-16(20)17-7-5-8-18-22(17)23-25-21(28)14-19(27(23)26-18)15-10-12-24-13-11-15/h3-9,14-15,24H,2,10-13H2,1H3,(H,25,28) QAZLKHYYYLSJRO-UHFFFAOYSA-N 290350 US10098883, Example 93::10-(2-Ethoxyphenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 93 Plasminogen [101-181] Human 28.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290350 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290350&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528632 381610678 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553882 CC(C)Oc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C24H26N4O2/c1-15(2)30-21-9-4-3-6-17(21)18-7-5-8-19-23(18)24-26-22(29)14-20(28(24)27-19)16-10-12-25-13-11-16/h3-9,14-16,25H,10-13H2,1-2H3,(H,26,29) TVVBPMOLYUMJHD-UHFFFAOYSA-N 290351 US10098883, Example 94::10-(2-Isopropoxyphenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 94 Plasminogen [101-181] Human 35.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290351 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290351&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528633 381610679 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553883 Fc1ccccc1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C21H19FN4O/c22-16-6-2-1-4-14(16)15-5-3-7-17-20(15)21-24-19(27)12-18(26(21)25-17)13-8-10-23-11-9-13/h1-7,12-13,23H,8-11H2,(H,24,27) VPTAHBAWJZYJEI-UHFFFAOYSA-N 290314 US10098883, Example 95::10-(2-Fluorophenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10098883, Example 57::US10668071, Example 95 Plasminogen [101-181] Human 18.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290314 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290314&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528598 381610644 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553884 O=c1cc(C2CCNCC2)n2nc3cccc(-n4cccn4)c3c2[nH]1 InChI=1S/C18H18N6O/c25-16-11-15(12-5-8-19-9-6-12)24-18(21-16)17-13(22-24)3-1-4-14(17)23-10-2-7-20-23/h1-4,7,10-12,19H,5-6,8-9H2,(H,21,25) QUHLGWOYWGATFZ-UHFFFAOYSA-N 290353 US10098883, Example 96::4-(Piperidin-4-yl)-10-(1H-pyrazol-1-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 96 Plasminogen [101-181] Human 26.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290353 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290353&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528634 381610680 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553885 COc1cccc(F)c1-c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 |(1.95,6.1,;1.55,4.62,;2.64,3.53,;4.13,3.93,;5.22,2.84,;4.82,1.35,;3.33,.95,;2.93,-.54,;2.24,2.04,;.7,2.04,;.08,3.45,;-1.46,3.61,;-2.36,2.36,;-1.73,.95,;-2.36,-.45,;-1.22,-1.48,;-1.22,-3.02,;.12,-3.79,;1.45,-3.02,;2.78,-3.79,;1.45,-1.48,;.12,-.71,;-.2,.79,;-2.55,-3.79,;-3.88,-3.02,;-5.22,-3.79,;-5.22,-5.33,;-3.88,-6.1,;-2.55,-5.33,)| InChI=1S/C22H21FN4O2/c1-29-18-7-3-5-15(23)20(18)14-4-2-6-16-21(14)22-25-19(28)12-17(27(22)26-16)13-8-10-24-11-9-13/h2-7,12-13,24H,8-11H2,1H3,(H,25,28) JQAUZOWOZDCFCX-UHFFFAOYSA-N 290354 US10098883, Example 97::10-(2-Fluoro-6-methoxyphenyl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 97 Plasminogen [101-181] Human 30.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290354 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290354&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528635 381610681 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553886 O=c1cc(C2CCNCC2)n2nc3cccc(-n4nccn4)c3c2[nH]1 InChI=1S/C17H17N7O/c25-15-10-14(11-4-6-18-7-5-11)23-17(21-15)16-12(22-23)2-1-3-13(16)24-19-8-9-20-24/h1-3,8-11,18H,4-7H2,(H,21,25) GPCIYULNMITCIW-UHFFFAOYSA-N 290355 US10098883, Example 98::4-(Piperidin-4-yl)-10-(2H-1,2,3-triazol-2-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 98 Plasminogen [101-181] Human 27.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290355 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290355&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528636 381610682 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553887 O=c1cc(C2CCNCC2)n2nc3cccc(-n4ccnn4)c3c2[nH]1 InChI=1S/C17H17N7O/c25-15-10-14(11-4-6-18-7-5-11)24-17(20-15)16-12(21-24)2-1-3-13(16)23-9-8-19-22-23/h1-3,8-11,18H,4-7H2,(H,20,25) YDNXTICCLATOHH-UHFFFAOYSA-N 290356 US10098883, Example 99::4-(Piperidin-4-yl)-10-(1H-1,2,3-triazol-1-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 99 Plasminogen [101-181] Human 29.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290356 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290356&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528637 381610683 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553888 Cc1ccc(Cl)c2c1nn1c(cc(=O)[nH]c21)C1CCNCC1 InChI=1S/C16H17ClN4O/c1-9-2-3-11(17)14-15(9)20-21-12(8-13(22)19-16(14)21)10-4-6-18-7-5-10/h2-3,8,10,18H,4-7H2,1H3,(H,19,22) ITROYPPTIOVFTM-UHFFFAOYSA-N 290357 US10098883, Example 100::10-Chloro-7-methyl-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 100 Plasminogen [101-181] Human 30.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290357 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290357&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528638 381610684 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553889 CC1CC(CCN1)c1cc(=O)[nH]c2c3c(Cl)cccc3nn12 InChI=1S/C16H17ClN4O/c1-9-7-10(5-6-18-9)13-8-14(22)19-16-15-11(17)3-2-4-12(15)20-21(13)16/h2-4,8-10,18H,5-7H2,1H3,(H,19,22) GBMDIIOZEVMRKC-UHFFFAOYSA-N 290358 US10098883, Example 101::(+)-Cis-10-Chloro-4-(2-methylpiperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one Plasminogen [101-181] Human 35.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290358 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290358&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528607 381610685 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553890 O=c1cc(C2CCNCC2)n2nc3cccc(-c4cnc[nH]4)c3c2[nH]1 InChI=1S/C18H18N6O/c25-16-8-15(11-4-6-19-7-5-11)24-18(22-16)17-12(14-9-20-10-21-14)2-1-3-13(17)23-24/h1-3,8-11,19H,4-7H2,(H,20,21)(H,22,25) VXCLPZVODVOKMF-UHFFFAOYSA-N 290359 US10098883, Example 103::10-(1H-imidazol-5-yl)-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 103 Plasminogen [101-181] Human 110 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290359 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290359&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528639 381610686 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553891 O=c1cc(C2CCNCC2)n2nc3cccc(-c4ccc[nH]4)c3c2[nH]1 InChI=1S/C19H19N5O/c25-17-11-16(12-6-9-20-10-7-12)24-19(22-17)18-13(14-5-2-8-21-14)3-1-4-15(18)23-24/h1-5,8,11-12,20-21H,6-7,9-10H2,(H,22,25) UAEFQLZDEJNRHU-UHFFFAOYSA-N 290360 US10098883, Example 104::4-(piperidin-4-yl)-10-(1H-pyrrol-2-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 104 Plasminogen [101-181] Human 35.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290360 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290360&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528640 381610687 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553892 Oc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H16N4O2/c20-12-3-1-2-10-14(12)15-17-13(21)8-11(19(15)18-10)9-4-6-16-7-5-9/h1-3,8-9,16,20H,4-7H2,(H,17,21) AFLUEAATNHVJTJ-UHFFFAOYSA-N 290361 US10098883, Example 105::10-hydroxy-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrobromide::US10668071, Example 105 Plasminogen [101-181] Human 74.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290361 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290361&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528641 381610688 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553893 OC(=O)c1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C16H16N4O3/c21-13-8-12(9-4-6-17-7-5-9)20-15(18-13)14-10(16(22)23)2-1-3-11(14)19-20/h1-3,8-9,17H,4-7H2,(H,18,21)(H,22,23) MGJWNNOTDHWJEC-UHFFFAOYSA-N 290362 US10098883, Example 106::2-oxo-4-(piperidin-4-yl)-1,2-dihydropyrimido[1,2-b]indazole-10-carboxylic acid hydrochloride::US10668071, Example 106 Plasminogen [101-181] Human 420 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290362 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290362&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528642 381610689 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553894 FC(F)(F)COc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C17H17F3N4O2/c18-17(19,20)9-26-13-3-1-2-11-15(13)16-22-14(25)8-12(24(16)23-11)10-4-6-21-7-5-10/h1-3,8,10,21H,4-7,9H2,(H,22,25) LTPLPFKZDXYQHW-UHFFFAOYSA-N 290363 US10098883, Example 107::4-(piperidin-4-yl)-10-(2,2,2-trifluoroethoxy)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 107 Plasminogen [101-181] Human 34.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290363 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290363&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528643 381610690 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 553895 Nc1cccc2nn3c(cc(=O)[nH]c3c12)C1CCNCC1 InChI=1S/C15H17N5O/c16-10-2-1-3-11-14(10)15-18-13(21)8-12(20(15)19-11)9-4-6-17-7-5-9/h1-3,8-9,17H,4-7,16H2,(H,18,21) FBRYWEWOAUMULU-UHFFFAOYSA-N 290364 US10098883, Example 108::10-amino-4-(piperidin-4-yl)pyrimido[1,2-b]indazol-2(1H)-one hydrochloride::US10668071, Example 108 Plasminogen [101-181] Human 35.0 7.0000 US Patent 10.7270/Q2G73GSM aid1795833 US10098883 Hasfeld, J; Kinzel, T; Kobberling, J; Cancho-Grande, Y; Beyer, K; Rohrig, S; Kollnberger, M; Sperzel, M; Burkhardt, N; Schlemmer, K; Stegmann, C; Schuhmacher, J; Werner, M; Ellermann, M 10/16/2018 2/18/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=290364 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=449&target=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=290364&enzyme=Plasminogen+%5B101-181%5D&column=ki&startPg=0&Increment=50&submit=Search 137528644 381610691 1 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILEC 1CEB,1CEA,4CIK,1PKR,1HPK,1HPJ,2DOI,2DOH,1KI0,8UQ6,4DUU,4DUR,4A5T Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00